Trials / Completed
CompletedNCT00580645
Do Treatments for Smoking Cessation Affect Alcohol Drinking?
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Yale University · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to examine the effect of smoking cessation medications on alcohol drinking. Effect of 2mg/day, 1mg/day, placebo varenicline was evaluated. Following 7 days of medication pre-treatment to achieve steady state levels, participants complete a laboratory session assessing alcohol self-administration behavior. Study enrolls heavy drinking smokers (not tested under nicotine deprivation), non-daily smokers, and nonsmokers. Volunteers are administered either varenicline (Chantix) or placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | varenicline | 2mg/day or 1mg/day with 1-week medication lead-in period. |
| DRUG | placebo | placebo |
Timeline
- Start date
- 2007-04-01
- Primary completion
- 2016-11-01
- Completion
- 2016-11-01
- First posted
- 2007-12-27
- Last updated
- 2018-02-07
- Results posted
- 2018-02-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00580645. Inclusion in this directory is not an endorsement.